Nantahala Capital Partners Limited Partnership 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-19 4:32 pm Purchase |
2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Partners Limited Partnership | 810,630 6.241% |
810,630 (New Position) |
Filing |